Related Experiment Video
Updated: Mar 26, 2026

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
Prolonged dual antiplatelet therapy in renal failure: a challenging trade-off
Matthias Bossard1, Raban Jeger1
11 Division of Cardiology, Hamilton General Hospital, Hamilton Health Sciences, McMaster University, Hamilton, ON L8L 2X2, Canada ; 2 Population Health Research Institute, David Braley Cardiac, Vascular and Stroke Research Institute, McMaster University, Hamilton, ON L8L 2X2, Canada ; 3 Cardiology Division, Department of Medicine, University Hospital Basel, Basel, Switzerland ; 4 Cardiovascular Research Institute Basel, University Hospital Basel, Basel, Switzerland.
No abstract available in PubMed .
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Continuous Renal Replacement Therapy
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Kidney Transplant II: Surgical Procedure
Peripheral Artery Disease III: Interprofessional Care

